The Unique Role of Fluorodeoxyglucose-PET in Radioembolization

Remco Bastiaannet, Martin A. Lodge, Hugo W.A.M. de Jong, Marnix G.E.H. Lam

Research output: Contribution to journalReview articlepeer-review


Recent research into the efficacy of radioembolization has brought this field to an interesting position, in which fluorodeoxyglucose (FDG)-PET/CT is being used extensively for prognosis and response assessment, as well as a tool to define viable tumor volumes for the use in dosimetry. As such, there is an overlap with existing techniques used in radiotherapy; however, many are very specific to the radioembolization paradigm. This article describes the current state-of-the-art of the use of FDG-PET/CT for patient selection, prognosis, treatment evaluation, and as a research tool into absorbed dose-response relationships in radioembolization.

Original languageEnglish (US)
Pages (from-to)447-457
Number of pages11
JournalPET Clinics
Issue number4
StatePublished - Oct 2019


  • Dose–response
  • Metabolic response assessment
  • Radioembolization

ASJC Scopus subject areas

  • Radiation
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'The Unique Role of Fluorodeoxyglucose-PET in Radioembolization'. Together they form a unique fingerprint.

Cite this